about
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...
Read More
13.13
0.03
(0.23%)
144.5K
XNAS Volume
XNAS 07 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for GlycoMimetics Inc is on 13 Nov 2025 for the purpose of GlycoMimetics Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
GlycoMimetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..